Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma

NCT00336843 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Zevalin-BuCyE

Sponsor

Asan Medical Center

Collaborators

[object Object]